COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,234 Articles (22,733 medRxiv, 8,501 bioRxiv)

Most recent first Previous |  Page 837: Articles 8361-8370  | Next

Modeling behavior change and underreporting in the early phase of COVID-19 pandemic in Metro Manila, Philippines
Mendoza, V. M. P., Mendoza, R., Ko, Y., Lee, J., Jung, E.
10.1101/2022.03.29.22273148 — Posted: 2022-04-05
Cannabis potential effects to prevent or attenuate SARS-COV2 contagion
Herrera-Gomez, P., Echeveri-Catano, L. F., Ruiz Colorado, Y. A., Giraldo Galeano, S., Velez van Meerbeke, A.
10.1101/2022.03.31.22273181 — Posted: 2022-04-05
EARLY OUTPATIENT TREATMENT OF COVID-19: A RETROSPECTIVE ANALYSIS OF 392 CASES IN ITALY
Cosentino, M., Vernocchi, V., Martini, S., Marino, F., Allasino, B., Balzola, M., Burigana, F., Dallari, A., Pagano, C. S. F., Palma, A., Rango, M.
10.1101/2022.04.04.22273356 — Posted: 2022-04-05
The network of SARS-CoV-2-cancer molecular interactions and pathways
Erola, P., Martin, R., Gaunt, T. R.
10.1101/2022.04.04.487020 — Posted: 2022-04-05
Time series analysis of SARS-CoV-2 genomes and correlations among highly prevalent mutations
Periwal, N., Rathod, S. B., Sarma, S., Johar, G., Jain, A., Barnwal, R. P., Srivastava, K. R., Kaur, B., Arora, P., Sood, V.
10.1101/2022.04.05.487114 — Posted: 2022-04-05
Combination of Baricitinib plus Remdesivir and Dexamethasone improves time to recovery and mortality among hospitalized patients with severe COVID-19 infection
Perez Gutierrez, V. A., Shah, V., Afzal, A., Khalid, A., Yangco, A., Ocrospoma, S., Cemalovic, N., Pillai, A., Kasubhai, M., Dimitrov, V., Menon, V.
10.1101/2022.04.04.22273425 — Posted: 2022-04-05
Determinants of mortality among COVID-19 patients with diabetes mellitus in Addis Ababa, Ethiopia, 2022: An unmatched case-control study
Sibhat, M. M., Getnet, M. T., Chane, W. Z., Gebeyehu, K. T., Habtamu, A. S., Mezgebu, T. A., Asmare, H. B., Ambaw, M. M., Getahun, E. M.
10.1101/2022.04.04.22273344 — Posted: 2022-04-05
Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study
Bouton, T. C., Atarere, J., Turcinovic, J., Seitz, S., Sher-Jan, C., Gilbert, M., White, L., Zhou, Z., Hossain, M. M., Overbeck, V., Doucette-Stamm, L., Platt, J., Landsberg, H. E., Hamer, D. H., Klapperich, C. M., Jacobson, K. R., Connor, J. H.
10.1101/2022.04.04.22273429 — Posted: 2022-04-05
Classification of Omicron BA.1, BA.1.1 and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data
Hirotsu, Y., Maejima, M., Shibusawa, M., Natori, Y., Nagakubo, Y., Hosaka, K., Sueki, H., Mochizuki, H., Tsutsui, T., Kakizaki, Y., Miyashita, Y., Omata, M.
10.1101/2022.04.03.22273268 — Posted: 2022-04-05
Low-dose IL-2 reduces IL-21+ T cells and induces a long-lived anti-inflammatory gene expression signature inversely modulated in COVID-19 patients
Zhang, J.-Y., Hamey, F., Trzupek, D., Mickunas, M., Lee, M., Godfrey, L., Yang, J. H. M., Pekalski, M. L., Kennet, J., Waldron-Lynch, F., Evans, M. L., Tree, T. I. M., Wicker, L. S., Todd, J. A., Ferreira, R. C.
10.1101/2022.04.05.22273167 — Posted: 2022-04-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).